Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

[Background] Different effectiveness profiles among antipsychotics may be a key point to optimize treatment in patients suffering a first episode of psychosis to impact on long-term outcome. The aim of this study is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripi...

Descripción completa

Detalles Bibliográficos
Autores: Gómez Revuelta, Marcos, Pelayo-Terán, José María, Juncal Ruiz, María, Vázquez-Bourgon, Javier, Suárez-Pinilla, Laura, Romero-Jiménez, Rodrigo, Setién-Suero, Esther, Ayesa Arriola, Rosa, Crespo-Facorro, Benedicto
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/238684
Acceso en línea:http://hdl.handle.net/10261/238684
Access Level:acceso abierto
Palabra clave:Schizophrenia
Antipsychotics
First-episode-psychosis
Descripción
Sumario:[Background] Different effectiveness profiles among antipsychotics may be a key point to optimize treatment in patients suffering a first episode of psychosis to impact on long-term outcome. The aim of this study is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, ziprasidone, and quetiapine in the treatment of first episode of psychosis at 3-year follow-up.

Similares en LA Referencia